midazolam has been researched along with Leukemia, Myeloid, Acute in 2 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heng, H | 1 |
| Zhi, Y | 1 |
| Yuan, H | 1 |
| Wang, Z | 1 |
| Li, H | 1 |
| Wang, S | 1 |
| Tian, J | 1 |
| Liu, H | 1 |
| Chen, Y | 1 |
| Lu, T | 1 |
| Ran, T | 1 |
| Lu, S | 1 |
| Bolleddula, J | 1 |
| Ke, A | 1 |
| Yang, H | 1 |
| Prakash, C | 1 |
2 other studies available for midazolam and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Drug Discovery; | 2019 |
PBPK modeling to predict drug-drug interactions of ivosidenib as a perpetrator in cancer patients and qualification of the Simcyp platform for CYP3A4 induction.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Caco-2 Cells; Cytochrome P-450 CYP3A | 2021 |